secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lunai Bioworks Inc. (LNAI)
CIK:        0001527728
Form:       8-K
Filed at:   2024-11-08T23:59:59+00:00
Accession:  0001731122-24-001750
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Renovaro amends consulting agreement with Interim CFO Simon Tarsh; $25k/month plus options
--------------------------------------------------------------------------------

- Simon Tarsh continues as Interim CFO under amended agreement; monthly fee $25,000.
- Tarsh received $29,063 bonus on Oct 31 and will receive another $29,063 on Nov 30.
- Granted 58,500 stock options under 2023 Equity Incentive Plan; vest if new CFO hired before termination.
- Agreement term is 3 months, renewable monthly; either party may terminate on 30 days notice.
- Tarsh eligible for target bonus up to 30% of total consideration if milestones achieved (timely SEC filings and new CFO).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1527728/000173112224001750/0001731122-24-001750-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1527728/000173112224001750/e6107_8k.htm
  HTML page:      https://secwatch.observer/filing/0001731122-24-001750

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer